CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 7 filers reported holding CRISPR THERAPEUTICS AG in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $262,355 | -7.4% | 5,780 | +14.6% | 0.02% | -5.9% |
| Q2 2023 | $283,227 | -33.5% | 5,045 | -46.4% | 0.02% | -41.4% |
| Q1 2023 | $425,660 | +56.7% | 9,411 | +40.9% | 0.03% | +45.0% |
| Q4 2022 | $271,583 | -30.4% | 6,681 | +11.8% | 0.02% | -31.0% |
| Q3 2022 | $390,000 | -12.0% | 5,974 | -18.0% | 0.03% | -9.4% |
| Q2 2022 | $443,000 | -48.9% | 7,289 | -47.2% | 0.03% | -34.7% |
| Q1 2022 | $867,000 | -2.6% | 13,803 | +17.5% | 0.05% | -2.0% |
| Q4 2021 | $890,000 | +27.0% | 11,747 | +87.7% | 0.05% | +8.7% |
| Q3 2021 | $701,000 | +16.4% | 6,259 | +68.4% | 0.05% | +9.5% |
| Q2 2021 | $602,000 | +89.3% | 3,716 | +42.3% | 0.04% | +68.0% |
| Q1 2021 | $318,000 | – | 2,611 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 508,558 | $82,330,000 | 27.28% |
| Valiant Capital Management, L.P. | 307,700 | $49,814,000 | 3.74% |
| NEA Management Company, LLC | 1,590,002 | $257,405,000 | 3.35% |
| NIA IMPACT ADVISORS, LLC | 39,891 | $6,458,000 | 3.15% |
| Ikarian Capital, LLC | 200,000 | $32,379,000 | 2.62% |
| Soleus Capital Management, L.P. | 103,114 | $16,693,000 | 2.57% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 157,334 | $25,471,000 | 2.47% |
| Capital Impact Advisors, LLC | 45,440 | $7,356,000 | 2.37% |
| ARK Investment Management | 7,776,119 | $1,258,876,000 | 2.34% |
| Sassicaia Capital Advisers LLC | 13,513 | $2,188,000 | 2.28% |